Switch region for pathogenic structural change in conformational disease and its prediction

PLoS ONE

Volumn 5, Issue 1, 2010, Pages

  Liu, Xin ^a   Zhao, Ya Pu ^a  

^a INSTITUTE OF MECHANICS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTRUCTURAL PROTEIN 1; NUCLEOPROTEIN;

ACCURACY; ALGORITHM; ARTICLE; CONFORMATIONAL DISEASE; CONFORMATIONAL TRANSITION; EPIDEMIC; IMMUNE RESPONSE; INFLUENZA VIRUS A; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H5N1; PANDEMIC; PATHOGENICITY; PREDICTIVE VALIDITY; PROTEIN ANALYSIS; PROTEIN DEFECT; PUBLIC HEALTH PROBLEM; SENSITIVITY AND SPECIFICITY; VIRUS VIRULENCE;

ALGORITHMS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA, HUMAN; MODELS, MOLECULAR; PROTEIN FOLDING; VIRULENCE;

ORTHOMYXOVIRIDAE; SUIDAE;

EID: 77952497087     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0008441     Document Type: Article

References (61)

1. Prusiner SB (1982) Novel proteinaceous infectious particles cause scrapie. Science 216: 136-144.
2. Prusiner SB (1998) Prions. Proc Natl Acad Sci USA 95: 13363-13383.
3. Carrell RW, Lomas DA (1997) Conformational disease. Lancet 350: 134-138.
4. Bornholdt ZA, Prasad VV (2008) X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature 456: 985-988.
5. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, et al. (2009) Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 325: 197-201.
6. Ventura S, Zurdo J, Narayanan S, Parrenon M, Mangues R, et al. (2004) Short amino acid stretches can mediate amyloid formation in globular proteins: the Src homology 3 (SH3) case. Proc Natl Acad Sci USA 101: 7258-7263.
7. Ivanova MI, Sawaya MR, Gingery M, Attinger A, Eisenberg D (2004) An amyloid-forming segment of beta2-microglobulin suggests a molecular model for the fibril. Proc Natl Acad Sci USA 101: 10584-10589.
8. Dobson CM (1999) Protein misfolding, evolution and disease. Trends Biochem Sci 24: 329-332.
9. Parthiban V, Gromiha MM, Schomburg D (2006) CUPSAT: prediction of protein stability upon point mutations. Nucleic Acids Res 34: w239-w242.
10. Liu X, Zhao YP (2009) Donut-shaped fingerprint in homologous polypeptide relationships - a topological feature related to pathogenic structural conversion of conformational disease. J Theor Biol 258: 294-301.
11. Kuwata K, Nishida N, Matsumoto T, Kamatari YO, Hosokawa-Muto J, et al. (2007) Hot spots in prion protein for pathogenic conversion. Proc Natl Acad Sci USA 104: 11921-11926.
12. Liu X, Zhang LM, Yin J, Zhao YP (2008) Major factors of protein evolution revealed by eigenvalue decomposition analysis. In: Arabnia HR, Yang MQ, Yang JY, eds. Proceeding of the international Conference on Bioinformatics and Computational Biology BIOCOMP'08. Las Vegas USA CSREA Press. pp 91-97.
13. Cobb NJ, Sönnichsen FD, Mchaourab H, Surewicz WK (2007) Molecular architecture of human prion protein amyloid: A parallel, in-register β-structure. Proc Natl Acad Sci USA 104: 18946-18951.
14. Carrell RW, Gooptu B (1998) Conformational changes and diseases-serpins, prions, and Alzheimer's. Curr Opin Struct Biol 8: 799-809.
15. Soto C (2001) Protein misfolding and disease; protein refolding and therapy. FEBS lett 498: 204-207.
16. Kelly JW (1996) Alternative conformations of amyloidogenic proteins govern their behavior. Curr Opin Struct Biol 6: 11-17.
17. Thomas PJ, Qu BH, Pedersen PL (1995) Defective protein folding as a basis of human disease. Trends Biochem Sci 20: 456-459.
18. Liu X, Zhao YP (2009) A scheme for multiple sequence alignment optimization - an improvement based on family representative mechanics features. J Theor Biol 261: 593-597.
19. Snyder MH, Buckler-White AJ, London WT, Tierney EL, Murphy BR (1987) The avian influenza virus nucleoprotein gene and a specific constellation of avian and human virus polymerase genes each specify attenuation of avianhuman influenza A/Pintail/79 reassortant viruses for monkeys. J Virol 61: 2857-2863.
20. Finkelstein DB, Mukatira S, Mehta PK, Obenauer JC, Su X, et al. (2007) Persistent host markers in pandemic and H5N1 influenza viruses. J Virol 81: 10292-10299.
21. Scholtissek C, Ludwig S, Fitch WM (1993) Analysis of influenza A virus nucleoproteins for the assessment of molecular genetic mechanisms leading to new phylogenetic virus lineages. Arch Virol 131: 237-250.
22. Berkhoff EG, de Wit E, Geelhoed-Mieras MM, Boon AC, Symons J, et al. (2005) Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes. J Virol 79: 11239-11246.
23. Berkhoff EG, Boon AC, Nieuwkoop NJ, Fouchier RA, Sintnicolaas K, et al. (2004) A mutation in the HLA-B*2705-restricted NP383-391 epitope affects the human influenza A virus-specific cytotoxic T-lymphocyte response in vitro. J Virol 78: 5216-5222.
24. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215: 403-410.
25. Reid AH, Fanning TG, Janczewski TA, Lourens RM, Taubenberger JK (2004) Novel origin of the 1918 pandemic influenza virus nucleoprotein gene. J Virol 78: 12462-12470.
26. Lee LY, Ha-do LA, Simmons C, de-Jong MD, Chau NV, et al. (2008) Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118: 3478-3490.
27. Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, et al. (1986) The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 44: 959-968.
28. Liu X, Zhang LM, Guan S, Zheng WM (2003) Distances and classification of amino acids for different protein secondary structures. Phys Rev E 67: 051927.
29. Jiménez JL, Nettleton EJ, Bouchard M, Robinson CV, Dobson CM, et al. (2002) The protofilament structure of insulin amyloid fibrils. Proc Natl Acad Sci USA 99: 9196-9201.
30. Ajees AA, Anantharamaiah GM, Mishra VK, Hussain MM, Murthy HMK (2006) Crystal structure of human apolipoprotein A-I: Insights into its protective effect against cardiovascular diseases. Proc Natl Acad Sci USA 103: 2126-2131.
31. Frank PG, Marcel YL (2000) Apoliproprotein A-I: structure-function relationship. J Lipid Res 41: 853-872.
32. Haspel N, Zanuy D, Ma B, Wolfson H, Nussinov R (2005) A comparative study of amyloid fibril formation by residues 15-19 of the human calcitonin hormone:A single β-sheet model with a small hydrophobic core. J Mol Biol 345: 1213-1227.
33. Kazantzis A, Waldner M, Taylor JW, Kapurniotu A (2002) Conformationally constrained human calcitonin(hCt) analogues reveal a critical role of sequence 17-21 for the oligomerization state and bioactivity of hCt. Eur J Biochem 269: 780-791.
34. Andreotti G, Vitale RM, Avidan-Shpalter C, Amodeo P, Gazit E, et al. Designing aggregation-resistant bioactive peptides by three-dimensional structure homology with a non-amyloidogenic analogue. To be Published.
35. Abrahamson M (1996) Molecular basis for amyloidosis related to hereditary brain hemorrhage. Scand J Clin Lab Invest 226: 47-56.
36. Olafsson I, Grubb A (2000) Hereditary cystatin C amyloid angiopathy. Amyloid Int J Exp Clin Invest 7: 70-79.
37. http://globin.cse.psu.edu/html/huisman/variants/beta/index.html.
38. Page LJ, Suk JY, Huff ME, Lim HJ, Venable J, et al. (2005) Metalloendoprotease cleavage triggers gelsolin amyloidogenesis. EMBO J 24: 4124-4132.
39. Johnson RJK, Christodoulou J, Dumoulin M, Caddy GL, Alcocer MJC, et al. (2005) Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme. J Mol Biol 352: 823-836.
40. Collod-Béroud G, Béroud C, Ades L, Black C, Boxer M, et al. (1998) Marfan Database (third edition): new mutations and new routines for the software. Nucleic Acids Res 26: 229-233.
41. Hasegawa K, Ohhashi Y, Yamaguchi I, Takahashi N, Tsutsumi S, et al. (2003) Amyloidogenic synthetic peptides of β2-microglobulin - a role of the disulfide bond. Biochem Biophys Res Commun 304: 101-106.
42. Hiramatsu H, Goto Y, Naiki H, Kitagawa T (2004) Core structure of amyloid fibril proposed from IR-microscope linear dichroism. J Am Chem Soc 126: 3008-3009.
43. 2-microglobulin #21-31 fragment based on vibrational spectroscopy. J Am Chem Soc 127: 7988-7989.
44. 2-microglobulin and its deamidated variant, N17D form amyloid fibrils with a range of morphologies in vitro. J Mol Biol 313: 559-571.
45. de Belleroche J, Orrell R, King A (1995) Familial amyotrophic lateral sclerosis/motor neurone disease (FALS): a review of current developments. J Med Genet 32: 841-847.
46. Jacobson DR, McFarlin DE, Kane I, Buxbaum JN (1992) Transthyretin Pro55, a variant associated with early-onset,aggressive, diffuse amyloidosis with cardiac and neurologic involvement. Hum Genet 89: 353-356.
47. Sebastiao MP, Saraiva MJ, Damas AM (1998) The crystal structure of amyloidogenic Leu55→Pro transthyretin variant reveals a possible pathway for transthyretin polymerization into amyloid fibrils. J Biol Chem 273: 24715-24722.
48. http://p53.free.fr/Database/p53-database.html.
49. Joerger AC, Ang HC, Fersht AR (2006) Structural basis for understanding oncogenic p53 mutations and designing rescue drugs. Proc Natl Acad Sci USA 103: 15056-15061.
50. http://www-p53.iarc.fr/stability.html.
51. Johnson DJD, Huntington JA (2004) The influence of hinge region residue Glu-381 on antithrombin allostery and metastability. J Biol Chem 279: 4913-4921.
52. Jung J, Byeon IJ, Wang Y, King J () Gronenborn A The structure of the cataract-causing P23T mutant of human gammaD-crystallin exhibits distinctive local conformational and dynamic changes. Biochemistry 48: 2597-2609.
53. Fass D, Blacklow S, Kim PS, Berger JM (1997) Molecular basis of familial hypercholesterolaemia from structure of LDL receptor module. Nature 388: 691-693.
54. http://www.genet.sickkids.on.ca/cftr/app.
55. http://www.molgen.ua.ac.be/Admutations/.
56. Coles M, Bicknell W, Watson AA, Fairlie DP, Craik DJ (1998) Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is? Biochemistry 37: 11064-11077.
57. Hardy J, Cai H, Cookson MR, Gwinn-Hardy K, Singleton A (2006) Genetics of Parkinson's disease and parkinsonism. Ann Neurol 60: 389-398.
58. Zhu M, Li J, Fink AL (2003) The Association of α-synuclein with membranes affects bilayer structure, stability, and fibril formation. J Bio Chem 278: 40186-40197.
59. Mclean PJ, Kawamata H, Ribich S, Hyman BT (2000) Membrane association and protein conformation of α-synuclein in intact neurons. J Bio Chem 275: 8812-8816.
60. Henneke M, Flaschker N, Helbling C, Müller M, Schadewaldt P, et al. (2003) Identification of twelve novel mutations in patients with classic and variant forms of maple syrup urine disease. Hum Mutat 22: 417.
61. http://www.uniprot.org/uniprot/P06865.